BeOne Medicines
ONC
#717
Rank
โ‚น3.065 T
Marketcap
โ‚น26,692
Share price
2.20%
Change (1 day)
18.61%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): โ‚น42.09 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are โ‚น5.34 Billion. , an increase over its 2024 earnings that were of -โ‚น53.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น44.80 B-183.61%
2024 -โ‚น53.59 Billion-52.95%
2023 -โ‚น113.91 Billion-32.52%
2022 -โ‚น168.79 Billion24.39%
2021 -โ‚น135.69 Billion-13.21%
2020 -โ‚น156.34 Billion72.69%
2019 -โ‚น90.53 Billion36.01%
2018 -โ‚น66.57 Billion616.83%
2017 -โ‚น9.29 Billion-15.24%
2016 -โ‚น10.96 Billion107.91%
2015 -โ‚น5.27 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น15.05 Billion-133.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.72 Billion-103.82%๐Ÿ‡บ๐Ÿ‡ธ USA